ARTICLE | Clinical News
Moxatag amoxicillin pulsys regulatory update
January 28, 2008 8:00 AM UTC
FDA approved an NDA from MiddleBrook (formerly Advancis Pharmaceutical Corp.) for 775 mg Moxotag extended-release amoxicillin tablets to treat patients aged 12 and up with pharyngitis/tonsillitis sec...